Clinical Trials Browser

Phase 3 × OTHER_GOV × Thoracic × Clear all

NCT05236946 2025-09-10

Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT

Phase 3 Recruiting

Asymptomatic Brain Metastases

NCT05278052 2025-09-10

TARGET-02

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07050043 2025-07-03

LEDANG

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06141070 2023-11-21

ANDROMEDA

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT02455843 2017-09-19

Microwave Plus Chemotherapy Versus Chemotherapy for Advanced NSCLC

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02896166 2017-06-14

Microwave Ablation in the Treatment of Stage I Non Small Cell Lung Cancer

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03008109 2017-01-04

Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02738346 2016-04-25

CBPC

Phase 3 Unknown

Small Cell Lung Carcinoma

NCT00864331 2013-08-07

Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00821860 2013-06-28

MesoVATS

Phase 3 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Neoplasm Metastasis, Pleural Effusion, Malignant, Solitary Fibrous Tumor, Pleural

NCT01836575 2013-04-22

PS2

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung

NCT00455936 2010-10-25

First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker

Phase 3 Completed

Adenocarcinoma, Lung Neoplasms

NCT01041833 2010-01-01

Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00268684 2006-02-28

Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis